Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China
· Delayed Price · Currency is CNY 34.11
-0.28 (-0.81%)
Mar 11, 2026, 12:44 PM CST
SHE:002864 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,642 | 3,198 | 4,047 | 3,319 | 2,680 | 2,159 | Upgrade
|
| Market Cap Growth | 26.97% | -20.99% | 21.96% | 23.82% | 24.13% | -9.34% | Upgrade
|
| Enterprise Value | 2,630 | 2,188 | 3,055 | 2,938 | 2,384 | 2,024 | Upgrade
|
| Last Close Price | 34.39 | 29.99 | 37.67 | 37.81 | 30.38 | 24.20 | Upgrade
|
| PE Ratio | 29.91 | 26.59 | 36.65 | 32.81 | 28.77 | 27.29 | Upgrade
|
| Forward PE | - | 74.31 | 74.31 | 74.31 | 74.31 | 74.31 | Upgrade
|
| PS Ratio | 3.32 | 3.28 | 4.13 | 3.41 | 3.02 | 3.22 | Upgrade
|
| PB Ratio | 2.16 | 1.95 | 2.61 | 3.50 | 3.32 | 2.94 | Upgrade
|
| P/TBV Ratio | 2.23 | 2.02 | 2.71 | 3.79 | 3.65 | 3.26 | Upgrade
|
| P/FCF Ratio | 80.71 | 42.90 | 97.45 | 47.73 | 75.80 | 102.54 | Upgrade
|
| P/OCF Ratio | 31.02 | 20.42 | 38.90 | 26.47 | 23.10 | 23.41 | Upgrade
|
| EV/Sales Ratio | 2.39 | 2.25 | 3.12 | 3.02 | 2.69 | 3.02 | Upgrade
|
| EV/EBITDA Ratio | 17.85 | 15.74 | 21.38 | 22.57 | 20.24 | 20.27 | Upgrade
|
| EV/EBIT Ratio | 23.40 | 20.54 | 27.01 | 25.98 | 23.14 | 23.70 | Upgrade
|
| EV/FCF Ratio | 58.28 | 29.35 | 73.55 | 42.26 | 67.43 | 96.10 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.07 | 0.45 | 0.18 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 1.02 | 1.09 | 0.71 | 3.25 | 1.20 | 1.02 | Upgrade
|
| Debt / FCF Ratio | 3.34 | 2.04 | 2.47 | 6.14 | 4.07 | 4.83 | Upgrade
|
| Net Debt / Equity Ratio | -0.60 | -0.62 | -0.64 | -0.42 | -0.34 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.90 | -7.32 | -6.99 | -3.04 | -2.34 | -2.81 | Upgrade
|
| Net Debt / FCF Ratio | -22.46 | -13.65 | -24.06 | -5.70 | -7.79 | -13.32 | Upgrade
|
| Asset Turnover | 0.47 | 0.44 | 0.48 | 0.60 | 0.71 | 0.64 | Upgrade
|
| Inventory Turnover | 4.89 | 4.41 | 4.80 | 5.06 | 5.56 | 4.11 | Upgrade
|
| Quick Ratio | 2.84 | 3.74 | 3.29 | 1.51 | 1.98 | 2.29 | Upgrade
|
| Current Ratio | 3.11 | 3.97 | 3.49 | 1.64 | 2.19 | 2.51 | Upgrade
|
| Return on Equity (ROE) | 7.30% | 7.52% | 8.93% | 11.76% | 12.26% | 11.50% | Upgrade
|
| Return on Assets (ROA) | 3.02% | 3.02% | 3.49% | 4.33% | 5.17% | 5.10% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.38% | 15.92% | 17.70% | 18.07% | 18.11% | 16.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 5.80% | 6.90% | 11.00% | 11.50% | 10.40% | Upgrade
|
| Earnings Yield | 3.31% | 3.76% | 2.73% | 3.05% | 3.48% | 3.66% | Upgrade
|
| FCF Yield | 1.24% | 2.33% | 1.03% | 2.10% | 1.32% | 0.97% | Upgrade
|
| Dividend Yield | 0.59% | 0.83% | 0.58% | 0.53% | 0.59% | 0.62% | Upgrade
|
| Payout Ratio | 35.59% | 20.39% | 22.00% | 20.84% | 19.20% | 20.88% | Upgrade
|
| Buyback Yield / Dilution | 2.47% | -7.02% | -13.03% | -1.16% | 0.60% | 0.56% | Upgrade
|
| Total Shareholder Return | 3.06% | -6.18% | -12.44% | -0.63% | 1.20% | 1.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.